Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening.
about
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancerAmerican Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.Clinical progression of high-grade cervical intraepithelial neoplasia: estimating the time to preclinical cervical cancer from doubly censored national registry data.Sexual behaviour and HPV infections in 18 to 29 year old women in the pre-vaccine era in the NetherlandsPopulation-based type-specific prevalence of high-risk human papillomavirus infection in Estonia.Prevalence and risk profile of cervical Human papillomavirus infection in Zhejiang Province, southeast China: a population-based study.Cervical HPV type-specific pre-vaccination prevalence and age distribution in Croatia.Sex-specific immunization for sexually transmitted infections such as human papillomavirus: insights from mathematical modelsA cross sectional study of HPV type prevalence according to age and cytologyA second generation cervico-vaginal lavage device shows similar performance as its preceding version with respect to DNA yield and HPV DNA resultsThe role of acquired immunity in the spread of human papillomavirus (HPV): explorations with a microsimulation model.Persistence of immune response to HPV-16/18 AS04-adjuvanted cervical cancer vaccine in women aged 15-55 yearsAge-group differences in human papillomavirus types and cofactors for cervical intraepithelial neoplasia 3 among women referred to colposcopyCervical Cancer Screening in Partly HPV Vaccinated Cohorts - A Cost-Effectiveness Analysis.Cervical cancer screening in the United States and the Netherlands: a tale of two countriesProgression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study.Human papillomavirus prevalence in women attending routine cervical screening in South Wales, UK: a cross-sectional studyThe prevalence of human papillomavirus and its impact on cervical dysplasia in Northern CanadaType- and age-specific distribution of human papillomavirus in women attending cervical cancer screening in Finland.Prevalence and type distribution of human papillomavirus in 5,000 British Columbia women--implications for vaccination.HPV vaccine: Cervarix.The human papillomavirus (HPV) vaccine and cervical cancer: uptake and next steps.High-risk human papillomavirus infection clearance following conization among patients with cervical intraepithelial neoplasm grade 3 aged at least 45 years.Association between human papillomavirus vaccine uptake and cervical cancer screening in the Netherlands: implications for future impact on prevention.Vaginal high-risk human papillomavirus infection in a cross-sectional study among women of six different ethnicities in Amsterdam, the Netherlands: the HELIUS study.Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infection.Public Health Benefits of Routine Human Papillomavirus Vaccination for Adults in the Netherlands: A Mathematical Modeling Study.Primary human papillomavirus DNA screening for cervical cancer prevention: Can the screening interval be safely extended?Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: a 14-year follow-up of a randomized primary HPV screening trial.Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.Cervarix®: a bivalent vaccine against HPV types 16 and 18, with cross-protection against other high-risk HPV types.High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas.Trends in cervical cancer in the Netherlands until 2007: has the bottom been reached?American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical CancerThe health impact of human papillomavirus vaccination in the situation of primary human papillomavirus screening: A mathematical modeling study
P2860
Q24607403-42452B27-70E0-42E8-B12E-8B3B2949D295Q26828840-654F48AE-9E94-45E4-B306-E84786549D3EQ30658080-B77164CB-736D-4E01-A01E-4695BE3B2F01Q33384636-7B1037FD-1598-46A2-BDF3-72E992F1DC93Q33737295-6042407E-05C6-4C26-97FC-1096ED60DBA3Q33803206-750B648F-E4B1-468F-B289-BE2031B4033AQ33888215-0ED8AB0E-E8D4-42BF-83D4-DF891F419346Q34113476-E60494D4-0FC1-462C-B264-2CCCEFCAC6A7Q34567575-93AFF534-6F97-4002-B3C0-4DC84080BBB6Q34703399-F7C269D4-8E75-47CC-B771-2417989AA3E4Q35038766-E7354392-ED0D-4480-8B97-1C65CA5234EAQ35577825-05EB4D94-EFF2-4419-9755-7C9DDEAE6648Q35699092-8C2CFE27-BC0A-47D7-ABD9-085E5BFAAA35Q35908482-AB2C6B50-CB55-4EF4-8AA7-6303460CFAD1Q36063746-00F8302C-1FB7-4789-B90A-33E675AE21A4Q36675963-6A6418E5-0193-489F-8ABE-31FD4F110B64Q37010572-956D6514-89E7-4CBD-9B9D-474DB330CC38Q37056980-740C4AFD-975D-43AE-B86D-3BB4C8F991A5Q37352574-81E9DED0-B66C-4DD1-BB05-3716ED3E4D2BQ37353483-F7F61F88-13A6-43C5-8461-3763A60FE736Q37687426-572B83AC-181D-4355-96B7-E61E29F46270Q37912062-7E4AFA8E-5AF1-4ED7-987E-3E7EAC48ED0EQ39014476-5582CA8F-432F-4C86-AE23-C9918EB41FF6Q39604503-2F143248-EC73-4F1B-93A3-8FA2C91DDA9BQ39759678-F9D6D08D-F015-4E8F-85A1-81B400AA1F1DQ39760748-F1FD1CE7-3574-41EB-A832-9140825451B7Q40688577-97A6DC2D-A0B9-457A-AC7A-16ACE0CA8160Q41611517-40E36226-978C-45E1-9D5E-4C5ACBE7161EQ42204957-6ECB61D0-9ECE-4042-94A2-4CA047AD4FFAQ43655015-532CD8F5-84F2-4774-992F-5C3644E9AB25Q47291087-D895B827-925F-4A88-B83B-591C690728CFQ49900329-0ECAAEDD-A687-4585-8D9C-EF7E253420A7Q51148254-48337F0C-9D8F-482A-9F23-756A46BF2258Q57089342-B678C98E-B64C-4199-97C6-E86A37AD9D4EQ58765533-83DAB191-0D6A-4EE4-9E36-D5B6CAD516E4
P2860
Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Age-dependent prevalence of 14 ...... tic vaccination and screening.
@ast
Age-dependent prevalence of 14 ...... tic vaccination and screening.
@en
type
label
Age-dependent prevalence of 14 ...... tic vaccination and screening.
@ast
Age-dependent prevalence of 14 ...... tic vaccination and screening.
@en
prefLabel
Age-dependent prevalence of 14 ...... tic vaccination and screening.
@ast
Age-dependent prevalence of 14 ...... tic vaccination and screening.
@en
P2093
P2860
P356
P1476
Age-dependent prevalence of 14 ...... tic vaccination and screening.
@en
P2093
C J L M Meijer
N W J Bulkmans
P J F Snijders
V M H Coupé
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604162
P407
P577
2008-01-08T00:00:00Z